Emergo Therapeutics
Durham
About Emergo Therapeutics
Emergo Therapeutics is a pharmaceutical startup that develops treatment options for flu-like illnesses. It is focused on developing drugs to modulate inflammatory cytokines and improve the functioning of the immune system in various potential indications, starting with infectious diseases. Emergo’s therapeutic interventions are focused on reducing the production of inflammatory cytokines from mast cells. Emergo is headquartered in Durham, North Carolina.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $16.0M
- Last round: Series Unknown (Oct 2020)
- Website: emergotherapeutics.com
Industries & Categories
Biopharma, Biotechnology, Clinical Trials, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/emergo-therapeutics-53136 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.